Member Info for Babbler2

2 days?!? Lol.

Mobile can't be read by computers... And ai computer algos.

Bloe finally moving....

12500 buy I mean.

Nice 10k buy down as sell. Delayed. Was above ask and was what started the rise.... Imo

ok - will just sit and watch it shoot to 20p on hype then!! :D

It does seem the II is done selling now as every buy moves it up... just need a few more buys to take it above £1.30. Around 20% free float or less?
Bobby Kalar
Octopus Investments
Miton Asset Management
And Canaccord Genuity

hold around 80% between them. Even after selling a few.

So... opinions on one of the top risers please? Is it worth buying TOM? Does seem undervalued at £6m mcap? Cash position? Ramped for placing? Thoughts?

Biome continues its strategy of developing products where there is specific customer demand for bio-based or biodegradable solutions. It was noted in the July 2018 trading update that two projects in particular are advancing encouragingly through the development phase and, if successful, could lead to substantial revenues in 2019 and 2020. These projects are both with new customers. One of them has now completed its technical development phase in the USA and commercial production is expected in 2019. The second project, being developed in continental Europe, has passed an important milestone in recent weeks and work continues to support an aggressive launch timetable with the customer with commercial revenues being anticipated in 2019. Additionally, in recent weeks an initial six-month feasibility study, supported by an international consumer goods company, has been completed and discussions are underway regarding a product launch in 2020.

"The Group had an outstanding first half to 2018 delivering an operating profit in the period. Opportunities within the Bioplastics division are increasing with substantial revenue potential in the medium term whilst the Stanelco RF division has delivered an exceptional start to the year. It is against this backdrop that Board remains confident in the Group's outlook for 2018."

OK mate... cant blame you as its risky (biom). Could re-rate on Thursdays... or day before in anticipation perhaps... I liked that programme on BBC4 hence temped... :)

ta... not in that one.

DYOR... Cant recommend you buy or sell - up to you. Gambling on recovery and oversold territory with £1.30 being current one to cross before next rise up.

Risky yes... but could do very well.

Not if you are a bit of a nervous holder... imo. If happy to see what next news is with the risk involved then up to you...

They will arrive... im sure.... enjoy while its "quiet"

It is good... and Im still hovering over the buy button pre 1st... spread is offputting though but guess that's same for all low freefloat shares...

If profit has boomed on the 1st this wont be at this price... imo.

PS - Told ya to buy some of the oversold one... (yu,)

Reminder... the results are out this week on the one I recommended last week below £5... its rising... (1st November).

BIOM - The Southampton bio plastics company... way undervalued imo. and low freefloat means boom on results (if good).

(£1.30 resistance here again... shhhhhh Im not allowed to comment)...

I would comment... but then I'm a ramper and this was overpriced at £1 apparently...

will enjoy my paper profits in silence... ;)

Having said that... People very bullish there... Rampers gallor spouting 30p by Xmas... So might be worth a trade still? Or is 10p going to be hard to crack?